1,https://www.reuters.com/article/brief-haemonetics-ceo-christopher-simons/brief-haemonetics-ceo-christopher-simons-2020-total-compensation-was-9-4-mln-vls-8-6-million-in-2019-idUSFWN2DL0GT,2020-06-08T10:50:40Z,BRIEF-Haemonetics CEO Christopher Simon's 2020 Total Compensation Was $9.4 Mln Vls $8.6 Million In 2019,June 8 (Reuters) - Haemonetics Corp:,* HAEMONETICS SAYS CEO CHRISTOPHER A. SIMON’S FY 2020 TOTAL COMPENSATION WAS $9.4 MILLION VERSUS $8.6 MILLION IN FY 2019 - SEC FILING,* HAEMONETICS SAYS 2020 CEO PAY RATIO WAS 214 TO 1. Source text: (bit.ly/3f1mQlF) Further company coverage:
2,https://www.reuters.com/article/brief-haemonetics-reports-blood-filter-s/brief-haemonetics-reports-blood-filter-supply-agreement-sale-of-puerto-rico-based-operations-to-gvs-idUSASA00SJS,2020-06-03T10:51:56Z,"BRIEF-Haemonetics Reports Blood Filter Supply Agreement, Sale Of Puerto Rico-Based Operations To GVS",June 3 (Reuters) - Haemonetics Corp:,"* HAEMONETICS ANNOUNCES BLOOD FILTER SUPPLY AGREEMENT AND SALE OF PUERTO RICO-BASED MANUFACTURING OPERATIONS TO GVS, S.P.A","* HAEMONETICS CORP - UPON CLOSING, CO WILL RETAIN ALL IP RIGHTS TO ITS PROPRIETARY BLOOD FILTERS CURRENTLY MANUFACTURED AT FAJARDO FACILITY",* HAEMONETICS CORP - HAEMONETICS EMPLOYEES WHO WORK IN FAJARDO FACILITY WILL BECOME GVS EMPLOYEES.,"* HAEMONETICS CORP - GVS WILL OBTAIN CERTAIN OPERATING ASSETS, INCLUDING MANUFACTURING EQUIPMENT AND INVENTORY AND A SUBLEASE TO FAJARDO FACILITY","* HAEMONETICS CORP - CO, GVS WILL ALSO ENTER INTO A LONG-TERM SUPPLY AND DEVELOPMENT AGREEMENT","* HAEMONETICS CORP - AGREEMENT WILL GRANT GVS EXCLUSIVE RIGHTS TO MANUFACTURE, SUPPLY BLOOD FILTERS CURRENTLY PRODUCED AT FAJARDO FACILITY FO Source text for Eikon: Further company coverage:"
3,https://www.reuters.com/article/brief-haemonetics-says-gpi-will-pay-co-1/brief-haemonetics-says-gpi-will-pay-co-14-mln-in-upfront-cash-at-closing-of-asset-transfer-idUSFWN2DA0LG,2020-05-28T22:23:38Z,BRIEF-Haemonetics Says GPI Will Pay Co $14 Mln In Upfront Cash At Closing Of Asset Transfer,May 28 (Reuters) - GPI SpA:,"* HAEMONETICS - UNDER TERMS OF ASSET PURCHASE AGREEMENT WITH GPI GROUP, GPI WILL PAY CO $14 MILLION IN UPFRONT CASH AT CLOSING OF ASSET TRANSFER Source: (bit.ly/3guMosZ) Further company coverage:"
4,https://www.reuters.com/article/brief-haemonetics-announces-sale-of-us-b/brief-haemonetics-announces-sale-of-u-s-blood-donor-management-software-solution-assets-to-the-gpi-group-idUSFWN2DA0LD,2020-05-28T21:55:07Z,BRIEF-Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group,May 28 (Reuters) - GPI SpA:,* HAEMONETICS ANNOUNCES SALE OF U.S. BLOOD DONOR MANAGEMENT SOFTWARE SOLUTION ASSETS TO THE GPI GROUP,* HAEMONETICS CORP - TRANSACTION IS EXPECTED TO CLOSE IN Q2 OF CALENDAR 2020 Source text for Eikon: Further company coverage:
5,https://www.reuters.com/article/brief-gpi-spa-to-acquire-haemonetics-us/brief-gpi-spa-to-acquire-haemonetics-u-s-blood-donor-software-assets-idUSFWN2DA0NM,2020-05-28T20:37:53Z,BRIEF-GPI SpA To Acquire Haemonetics U.S. Blood Donor Software Assets,May 28 (Reuters) - GPI SpA:,"* GPI S.P.A. - BLOOD MANAGEMENT, GPI TO ACQUIRE HAEMONETICS U.S. BLOOD DONOR SOFTWARE ASSETS",* GPI SPA - AGREED PURCHASE PRICE IS $ 14 MILLION (USD) IN UPFRONT CASH AND UP TO $ 14 MILLION IN ADDITIONAL CASH CONSIDERATION,"* GPI SPA - ASSETS TO BE ACQUIRED REPRESENT TOTAL ANNUAL REVENUES OF ABOUT $11,3 MILLION",* GPI SPA - ASSET ACQUISITION WILL BE FINANCED BY MEANS OF PART OF MINI BOND ISSUED IN DECEMBER 2019 Source text for Eikon: Further company coverage:
6,https://www.reuters.com/article/brief-haemonetics-reports-q4-adjusted-ea/brief-haemonetics-reports-q4-adjusted-earnings-per-share-0-69-idUSFWN2CM1GN,2020-05-05T11:32:36Z,BRIEF-Haemonetics Reports Q4 Adjusted Earnings Per Share $0.69,May 5 (Reuters) - Haemonetics Corp:,"* Q4 EARNINGS PER SHARE VIEW $0.73, REVENUE VIEW $246.5 MILLION -- REFINITIV IBES DATA",* WILL PRIORITIZE ALLOCATING CAPITAL TO SUPPORT ITS BUSINESS NEEDS FIRST.,* NOT ISSUING ANNUAL GUIDANCE AT THIS TIME. Source: (bit.ly/2SCMYuu) Further company coverage:
7,https://www.reuters.com/article/brief-haemonetics-acquires-enicor-gmbh-t/brief-haemonetics-acquires-enicor-gmbh-to-expand-advanced-viscoelastic-testing-portfolio-idUSFWN2BQ0K2,2020-04-02T11:13:00Z,BRIEF-Haemonetics Acquires Enicor GmbH To Expand Advanced Viscoelastic Testing Portfolio,April 2 (Reuters) - Haemonetics Corp:,* HAEMONETICS ACQUIRES ENICOR GMBH TO EXPAND ADVANCED VISCOELASTIC TESTING PORTFOLIO,* HAEMONETICS CORP - HAS ACQUIRED ALL OF OUTSTANDING SHARE CAPITAL OF ENICOR GMBH Source text for Eikon: Further company coverage:
8,https://www.reuters.com/article/brief-haemonetics-appoints-anila-lingamn/brief-haemonetics-appoints-anila-lingamneni-executive-vice-president-chief-technology-officer-idUSASA00JDY,2020-03-30T21:25:20Z,"BRIEF-Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer",March 30 (Reuters) - Haemonetics Corp:,"* HAEMONETICS APPOINTS ANILA LINGAMNENI EXECUTIVE VICE PRESIDENT, CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:"
9,https://www.reuters.com/article/brief-haemonetics-reports-qtrly-earnings/brief-haemonetics-reports-qtrly-earnings-per-share-of-0-22-idUSFWN1SF0JW,2018-05-08T10:12:44Z,BRIEF-Haemonetics Reports Qtrly Earnings Per Share Of $0.22,May 8 (Reuters) - Haemonetics Corp:,* SEES FISCAL 2019 TOTAL REVENUE GROWTH 3 PERCENT TO 5 PERCENT,* SEES FISCAL 2019 ADJUSTED EARNINGS PER SHARE $2.00 - $2.30,* SEES FISCAL 2019 CASH FLOW FROM OPERATING ACTIVITIES (GAAP) $150 - $175 MILLION,"* Q4 EARNINGS PER SHARE VIEW $0.42, REVENUE VIEW $227.1 MILLION -- THOMSON REUTERS I/B/E/S","* FY EARNINGS PER SHARE VIEW $2.09, REVENUE VIEW $937.0 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:"
